Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biote Corp BTMD

Consumer Defensive Financial Services Education & Training Services
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that... see more

Recent & Breaking News (NDAQ:BTMD)

Biote Reports Third Quarter 2024 Financial Results

Business Wire November 12, 2024

Biote Schedules Third Quarter 2024 Financial Results Release and Conference Call

Business Wire October 29, 2024

Biote Reports Second Quarter 2024 Financial Results

Business Wire August 8, 2024

Biote Schedules Second Quarter 2024 Financial Results Release and Conference Call

Business Wire July 25, 2024

Biote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout Shares

Business Wire June 20, 2024

Biote Reports First Quarter 2024 Financial Results

Business Wire May 7, 2024

Biote Announces Definitive Settlement with Founder

Business Wire April 29, 2024

Biote Schedules First Quarter 2024 Financial Results Release and Conference Call

Business Wire April 23, 2024

Biote Reports Fourth Quarter and Full Year 2023 Financial Results

Business Wire March 12, 2024

Biote Schedules Fourth Quarter and Full Year 2023 Financial Results Release and Conference Call

Business Wire February 27, 2024

Biote Announces Agreement to Resolve Litigation and Repurchase All of Founder's Shares

Business Wire February 20, 2024

Biote Announces $20 Million Share Repurchase Authorization

Business Wire January 25, 2024

Biote to Purchase Asteria Health

Business Wire January 17, 2024

Biote Provides Preliminary 2023 Results and Initial 2024 Guidance

Business Wire January 17, 2024

Biote Names Robert Peterson as Chief Financial Officer

Business Wire January 11, 2024

Biote Reports Third Quarter 2023 Financial Results

Business Wire November 7, 2023

Biote Schedules Third Quarter 2023 Financial Results Release and Conference Call

Business Wire October 24, 2023

Biote Reports Second Quarter 2023 Financial Results

Business Wire August 10, 2023

Biote Schedules Second Quarter 2023 Financial Results Release and Conference Call

Business Wire July 27, 2023

Haymaker Acquisition Corp. 4 Announces Pricing of $200 Million Initial Public Offering

PR Newswire July 25, 2023